A new study found that the advertisements can be confusing and misleading. Here’s how to make smart buying decisions.
Category: Centers for Medicare and Medicaid Services
-
Federal Officials Propose New Nursing Home Standards to Increase Staffing
Citing worker shortages, nursing home operators said the standard could not be met without additional funding for higher wages.
-
Drugmakers Throw ‘Kitchen Sink’ to Halt Medicare Price Negotiations
The government will soon announce the first 10 medications that will be subject to price negotiations with Medicare under a new law. Drugmakers are fighting the measure in court.
-
Health Insures Deny Medical Care for the Poor at High Rates, Report Says
Investigators found that major companies overseeing Medicaid patients’ health care frequently rejected doctors’ requests for approval of treatments and procedures.
-
FDA Makes Alzheimer’s Drug Leqembi Widely Accessible
The F.D.A. gave full approval to the drug, but added a black-box warning about safety risks. Medicare said it would cover most of the high cost.
-
Medicare Tries to Combat Fraud. Now Insurers Are Fighting Back.
The New York Times – Business:The Biden administration has proposed changes to how it would pay private Medicare Advantage plans, setting off a lobbying frenzy.
-
Senator Elizabeth Warren Criticizes Medigap Sales Incentives in New Report
The New York Times – Business:Senator Elizabeth Warren has issued a report urging oversight of insurance brokers who are being offered financial incentives to push more expensive plans.
-
Emailing Your Doctor May Carry a Fee
The New York Times – Business:More hospitals and medical practices have begun charging for doctors’ responses to patient queries, depending on the level of medical advice.
-
Regulators Announce Changes to Nursing Home Rating System
The New York Times – Business:The federal agency that oversees nursing homes has tightened rules around the use of powerful antipsychotic drugs.
-
F.D.A. Approves New Treatment for Early Alzheimer’s
The New York Times – Business:The drug, Leqembi, may modestly slow cognitive decline in early stages of the disease but carries some safety risks. Still, data suggests it is more promising than the small number of other available treatments.
-
U.S. Health Officials Seek New Curbs on Private Medicare Advantage Plans
The New York Times – Business:Proposed regulations would crack down on misleading ads for the private plans and would enhance scrutiny of denials for coverage of medical care.
-
A Rural Hospital’s Excruciating Choice: $3.2 Million a Year or Inpatient Care?
The New York Times – Business:A new federal program offers hefty payments to small hospitals at risk of closing. But it comes with a bewildering requirement: to end all inpatient care.